title: Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning.
authors.forename: Jaap C
authors.initials: JC
authors.lastname: Reijneveld
authors.forename: Martin
authors.initials: M
authors.lastname: Klein
authors.forename: Martin Jb
authors.initials: MJ
authors.lastname: Taphoorn
authors.forename: Tjeerd J
authors.initials: TJ
authors.lastname: Postma
authors.forename: Jan J
authors.initials: JJ
authors.lastname: Heimans
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy / Q000523:psychology / Q000532:radiotherapy / Q000628:therapy*; D059248:Chemoradiotherapy; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D003071:Cognition / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D005910:Glioma / Q000188:drug therapy / Q000523:psychology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008134:Long-Term Care; D057285:Precision Medicine / Q000379:methods*; D016032:Randomized Controlled Trials as Topic